Efficacy and safety of bronchial artery embolization for the control of hemoptysis in patients with mycobacterium avium complex lung disease

K. Okuda, M. Kawashima, K. Masuda, J. Suzuki, N. Ohshima, H. Matsui, A. Yamane, A. Tamura, H. Nagai, S. Akagawa, K. Ohta (Kiyose City, Japan)

Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Session: Interventions and other therapeutic approaches in respiratory infections
Session type: Poster Discussion
Number: 240
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Okuda, M. Kawashima, K. Masuda, J. Suzuki, N. Ohshima, H. Matsui, A. Yamane, A. Tamura, H. Nagai, S. Akagawa, K. Ohta (Kiyose City, Japan). Efficacy and safety of bronchial artery embolization for the control of hemoptysis in patients with mycobacterium avium complex lung disease. Eur Respir J 2014; 44: Suppl. 58, 240

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Analysis of clinical course after pulmonary resection for mycobacterium avium complex lung disease in our hospital
Source: International Congress 2014 – Infection, thoracic trauma and congenital lesions
Year: 2014


Efficacy and safety of kanamycin addition in patients with drug-refractory mycobacterium avium complex lung disease
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015


Characteristics of pulmonary MAC disease diagnosed later in follow-up after negative mycobacterial cultures by bronchoscopy
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014


Cavitary formation in non-tuberculous mycobacterial infection is the significant risk for development to chronic pulmonary aspergillosis
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014


Clinical analysisof patients with pulmonary nontuberculous mycobacterial disease complicated with pneumothorax
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013

Disseminated nontuberculous infections with Mycobacterium genavense during sarcoidosis
Source: Eur Respir Rev 2009; 18: 299-301
Year: 2009



Asthma as a sequelae to pulmonary tuberculosis
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017

Management of pulmonary tuberculosis sequelae
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015


Nontuberculous mycobacteria lung infection in bronchiectasis: Prevalence and clinical characteristics
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014

Clinical characteristics and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014

Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Bronchial artery embolisation in the management of haemoptysis in pulmonary tuberculosis
Source: Annual Congress 2011 - To stent or not to stent: interventional bronchoscopy
Year: 2011

Clinical characteristics of pulmonary nocardiosis in immunocompetent patients
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015

Management of secondary pneumothorax in lung infections with Mycobacterium tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 525s
Year: 2001

Recurrence of pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 504s
Year: 2006

Pulmonary aspergilloma complicated by a cavitary lesion caused by pulmonary Mycobacterium avium complex disease
Source: Eur Respir J 2005; 26: Suppl. 49, 689s
Year: 2005

Management of pulmonary nontuberculous mycobacteria disease
Source: Eur Respir Monogr 2018; 81: 222-237
Year: 2018


Clinical study of mycobacterium avium complex pulmonary disease complicated by interstitial pneumonia
Source: Annual Congress 2011 - Non-tuberculous mycobacteria pulmonary infections
Year: 2011

Prediction of complications after pneumonectomy in patients with pulmonary tuberculosis
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015


Treatment outcomes of pulmonary tuberculosis cases in Izmit/Turkey
Source: Eur Respir J 2004; 24: Suppl. 48, 651s
Year: 2004